重症监护病房收治的COVID-19患者肺血栓栓塞症发生率:观察性研究的Meta分析与Meta回归
该Meta分析纳入14项观察性研究、共1182例ICU收治的COVID-19患者,几乎全部接受了至少预防性抗凝。肺血栓栓塞症加权平均发生率为11.1%(95%CI 7.7%–15.7%,I²=78%,Cochran's Q检验P<0.01)。单因素和多因素Meta回归显示男性比例是异质性的显著来源(P=0.03,95%CI 0.00至-0.09)。作者认为,即使预防性抗凝后肺血栓栓塞症发生率仍高,是COVID-19尤其是ICU危重患者的重要并发症。
要点
- ICU收治的COVID-19患者肺血栓栓塞症加权平均发生率为11.1%(95%CI 7.7%–15.7%)。
- 该发生率来自几乎全部接受至少预防性抗凝的患者群体。
- 研究间异质性高:I²=78%,Cochran's Q检验P<0.01。
- 男性比例是异质性的显著来源(P=0.03,95%CI 0.00至-0.09)。
- 作者认为肺血栓栓塞症是COVID-19尤其是ICU危重患者的重要并发症。
适用人群与场景
- ICU收治的COVID-19患者,几乎全部接受了至少预防性抗凝。
研究设计与关键结果
- 研究类型为观察性研究的Meta分析与Meta回归,纳入14项研究、共1182例患者。
- 肺血栓栓塞症加权平均发生率为11.1%(95%CI 7.7%–15.7%,I²=78%,Cochran's Q检验P<0.01)。
- 单因素和多因素Meta回归显示男性比例是异质性的显著来源(P=0.03,95%CI 0.00至-0.09)。
证据类型、等级与局限
- 证据类型:观察性研究的Meta分析与Meta回归;偏倚风险采用ROBINS-I工具评估。
- 局限:异质性I²=78%(Cochran's Q检验P<0.01);原文报告男性比例为异质性来源(P=0.03,95%CI 0.00至-0.09)。
对床旁实践的改变
- 作者认为,即使预防性抗凝后肺血栓栓塞症发生率仍高,是COVID-19尤其是ICU危重患者的重要并发症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Coronavirus disease 2019 (COVID-19) infection is associated with a prothrombotic state. We performed a meta-analysis of proportions to estimate the weighted average incidence of pulmonary thromboembolism (PTE) in COVID-19 patients who were admitted to the intensive care unit (ICU).
METHODS: We searched various medical databases for relevant studies from 31 December 2019 till 30 September 2020. We included observational studies that reported the incidence of PTE in COVID-19 patients admitted to the ICU. We extracted data related to study characteristics, patient demographics, and the incidence of PTE. Risk of bias was assessed by using the ROBINS-I tool. Statistical analysis was performed with R 3.6.3.
RESULTS: We included 14 studies with a total of 1182 patients in this study. Almost all patients in this meta-analysis received at least prophylactic anticoagulation. The weighted average incidence of PTE was 11.1% (95% CI 7.7% to 15.7%, I2 = 78%, Cochran's Q test P < 0.01). We performed univariate and multivariate meta-regression, which identified the proportion of males as a significant source of heterogeneity (P = 0.03, 95% CI 0.00 to - 0.09) CONCLUSION: The weighted average incidence of PTE remains high even after prophylactic anticoagulation. PTE is a significant complication of COVID-19 especially in critically ill patients in the ICU.
参考来源
- Ng JJ, Liang ZC, Choong AMTL, et al. The incidence of pulmonary thromboembolism in COVID-19 patients admitted to the intensive care unit: a meta-analysis and meta-regression of observational studies. J Intensive Care. 2021. PMID: 33618760. doi:10.1186/s40560-021-00535-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。